Skip to main content
. 2022 Jun 12;12(6):962. doi: 10.3390/jpm12060962

Table 4.

Multivariate analysis of the prognostic factors of disease-free survival in patients with stage II/III gastric cancer.

Factors Hazard Ratio 95% Confidence Interval p Value
Lower Upper
Type of gastrectomy
Total/partial 1.149 1.000 1.319 0.050
Tumor size (cm)
2.41–3.9/≤2.4 1.167 0.913 1.491 0.217
3.91–9.4/≤2.4 1.397 1.113 1.754 0.004
>9.4/≤2.4 1.581 1.177 2.124 0.002
Stage (AJCC eighth edition)
IIB/IIA 1.598 1.108 2.306 0.012
IIIA/IIA 1.766 1.232 2.531 0.002
IIIB/IIA 1.998 1.344 2.971 <0.001
IIIC/IIA 2.283 1.493 3.492 <0.001
LN ratio
0.051–0.15/≤0.05 1.595 1.239 2.053 <0.001
0.151–0.37/≤0.05 2.364 1.817 3.075 <0.001
0.371–0.53/≤0.05 3.116 2.270 4.276 <0.001
>0.53/≤0.05 4.570 3.288 6.354 <0.001
Histological type
Differentiated/undifferentiated 1.029 0.896 1.182 0.685
Vascular invasion
Yes/no 1.074 0.918 1.256 0.374
Lymphatic invasion
Yes/no 1.161 0.963 1.400 0.118
Perineural invasion
Yes/no 1.227 1.063 1.415 0.005

AJCC—American Joint Committee on Cancer; LN ratio—metastatic to examined lymph node ratio.